Claudin 19 anticorps
-
- Antigène Voir toutes Claudin 19 (CLDN19) Anticorps
- Claudin 19 (CLDN19)
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Claudin 19 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain, Souris, Rat
- Purification
- Antigen affinity purification
- Immunogène
- Synthetic peptide of Human CLDN19
- Isotype
- IgG
- Top Product
- Discover our top product CLDN19 Anticorps primaire
-
-
- Indications d'application
- ELISA:1:2000-1:5000, IHC:1:25-1:100,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- Claudin 19 (CLDN19)
- Autre désignation
- CLDN19 (CLDN19 Produits)
- Synonymes
- anticorps HOMG5, anticorps claudin-19, anticorps zgc:112141, anticorps claudin 19, anticorps claudin 19 S homeolog, anticorps CLDN19, anticorps Cldn19, anticorps cldn19.S, anticorps cldn19
- Sujet
-
Background: The product of this gene belongs to the claudin family. It plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. Defects in this gene are the cause of hypomagnesemia renal with ocular involvement (HOMGO). HOMGO is a progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene.
Aliases: CLDN19Claudin-19 antibody
- UniProt
- Q8N6F1
- Pathways
- Cell-Cell Junction Organization, Hepatitis C
-